Clinical Trials Logo

Gender clinical trials

View clinical trials related to Gender.

Filter by:

NCT ID: NCT06357325 Completed - Clinical trials for Nurse-Patient Relations

2023 Problems Faced by Women Earthquake Survivors in Kahramanmaraş

Start date: June 22, 2023
Phase:
Study type: Observational [Patient Registry]

Objective: This study was conducted to evaluate the opinions of earthquake victims about the problems affecting women's health physically and psychosocially after the 2023 Kahramanmaraş earthquake. Method: The study was designed in a qualitative type (semi-structured). The population of the study consisted of women affected by the 2023 Kahramanmaraş-Pazarcık earthquake. 15 women were interviewed.

NCT ID: NCT06345573 Active, not recruiting - Myocardial Ischemia Clinical Trials

Heart-brain-axis and Psychosocial Stress

Start date: October 11, 2021
Phase:
Study type: Observational

The main study objective is to prospectively determine the influence of sex-related risk factors and psychosocial variables on neuronal stress responses and myocardial perfusion in a population of 64 female and male individuals 50-75 years of age and free of cardiovascular disease.

NCT ID: NCT06230770 Not yet recruiting - Contraception Clinical Trials

Impact of Progestin-only Contraception on Bleeding Patterns in Individuals Initiating GATT

Start date: February 1, 2024
Phase:
Study type: Observational

Gender diverse individuals who use gender-affirming testosterone therapy (GATT) to reduce gender dysphoria may also use progestins for contraception and to manage or suppress uterine bleeding. Research is limited, however, regarding expected bleeding patterns for individuals who choose to initiate GATT concurrently with a progestin. Clinicians who prescribe GATT do not have sufficient data to adequately counsel patients on side effects of concurrent progestin use and therefore extrapolate from studies conducted in cisgender women. This study is a prospective cohort study evaluating bleeding patterns and satisfaction among patients initiating GATT with or without concurrent initiation of a progestin contraceptive. The results from this study will enable clinicians to more accurately counsel patients using GATT on how the use of a progestin might affect their bleeding and whether this differs by progestin method.

NCT ID: NCT06138119 Completed - Clinical trials for Intubation; Difficult or Failed

The Impact of Gender Stereotypes on Fiberoptic Intubation Performance

Start date: November 15, 2023
Phase: N/A
Study type: Interventional

Gender bias and stereotypes have been recognized as pervasive factors influencing various aspects of society, including professional settings. Within the realm of medical practice, understanding the potential impacts of such biases on performance is of paramount importance. Anesthesiology, a field that demands technical precision, teamwork, and rapid decision-making, is not immune to the potential effects of gender stereotypes on performance outcomes. This study aims to explore the potential influence of gender stereotype manipulation and stereotype threat on the fiber-optic intubation (FOE) performance of female anesthesiology residents. Stereotype threat refers to the apprehension individuals experience when their actions or abilities are evaluated within the context of negative stereotypes associated with their social group. Such threat has been shown to adversely affect cognitive and motor performance in various domains. In medical education, where skills are honed through training, understanding the role of stereotype threat is crucial to fostering equitable learning environments and ensuring patient safety.

NCT ID: NCT06018623 Not yet recruiting - Anesthesia Clinical Trials

Dosage of Propofol Based on Lean Body Weight

Start date: May 15, 2024
Phase:
Study type: Observational

Patients who will be anesthesia induced with propofol will be body analyzed with Tanita before the operation. Height, weight, age, gender and other general information of the patients will be recorded. Total body weight (TBW), ideal body weight (IBW) and lean body weight (LBW) will be calculated. Patients over 18 years of age who will be operated under general anesthesia for 2-6 hours will be included. Patients allergic to propofol or contraindicated to propofol will be excluded. In the study, in order to decide and test the most appropriate weight-based scale for the evaluation of propofol dosage for induction of anesthesia by identifying patients who need additional propofol during intubation, Ingrande et al. After monitoring, propofol infusion (100 mg/kg/hour) will be started according to total body weight and the infusion will be stopped when the BIS value is between 50 and 40 and the elapsed time will be recorded. Routine anesthesia applications will be performed by applying neuromuscular blocker. Total Propofol dose administered will be calculated according to the dose TBW, IBW and LBW in kilograms. The relationship between the doses administered and body mass index will be evaluated.

NCT ID: NCT06016283 Completed - Gender Clinical Trials

The Impact of Gender on Graft Outcomes Following Living Donor Kidney Transplantation

Start date: April 1, 2022
Phase:
Study type: Observational

The impact of donor and recipient gender combination on kidney transplant outcomes has been reported in several studies. The results vary greatly due to different factors, such as minor histocompatibility antigens, nephron overload, sex hormones, etc. Despite advancements in clinical practice, no large-scale studies exploring this question in living donor kidney transplantation have been conducted in the subsequent two decades. Our study aims to address this research gap and provide updated information on outcomes in relation to the gender combination following living donor kidney transplantation.

NCT ID: NCT05789667 Recruiting - Clinical trials for Differentiated Thyroid Cancer

Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Differentiated Thyroid Cancer

Gisel
Start date: May 27, 2020
Phase:
Study type: Observational

Lenvatinib is approved for the treatment of radioiodine refractory differentiated thyroid cancer. Despite gender can play a crucial role un in safety and efficacy of oncological product, little is know on gender difference in lenvatinb effacacy and safety in the context of radioiodine refractory differentiated thyroid cancer. The primary objective of the study is to assess safety and toxicity profile in male and female patients in terms of dose reduction. The secondary objectives are to assess sex and gender difference in: the number and the incidence of adverse events; response rate according to RECIST criteria 1.1; progression free survival, overall survival and duration of response.

NCT ID: NCT05735769 Completed - Clinical trials for Vaccine Adverse Reaction

Anti-COVID-19 Vaccine Side Effects

VAX-IT-LEB
Start date: January 1, 2021
Phase:
Study type: Observational

In 2021 and following the COVID-19 (corona virus disease 2019) pandemic, different vaccines were initially authorized in Italy and Lebanon. Notably, vaccine side effects were poorly recorded. Thus, the investigator performed a survey study to monitor COVID-19 vaccine side effects among Italian and Lebanese citizens according to gender and age through a web-based questionnaire in Italian and Arabic languages including 21 items by "Google Form", investigating 13 symptoms, and employing social-media platforms

NCT ID: NCT05686187 Not yet recruiting - Empowerment Clinical Trials

Establishing and Evaluating the Effectiveness of an Augmented Reality Technology in Gender Empowerment System

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

Background: In the interventional study of gender mainstreaming, few studies have been conducted on gender empowerment in long-term care. And there are still some limitations in the gender curriculum of current in-service education. This research will cooperate with the digital learning promotion plan to stimulate learners' senses to strengthen their feelings about gender equality issues and events to have a more flexible and diverse learning experience and enhance geriatric care competencies. Purpose: This study is a two-year plan, and the purpose of each year are as follows: 1). To conduct learning needs assessment of long-term care workers, and to develop and construct an educational training module for gender empowerment system of AR interactive experience. 2). To verify the effectiveness of the gender equality knowledge, attitude, awareness, and self-confidence of the research subjects after the "Apply of augmented reality technology" was introduced into the gender curriculum.

NCT ID: NCT05618119 Not yet recruiting - Gender Clinical Trials

[18F]MC225 PET to Evaluate Gender Differences in BBB P-gp Function

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

P-gp is one of the main efflux transporters at the blood-brain barrier and is responsible for the transport of a variety of neurotoxic substances, including pharmaceuticals. Multiple studies report gender differences in therapeutic outcomes, toxicity and side effects for many drug agents. P-gp plays an important role in the bio-availability, drug distribution, metabolism and elimination of pharmaceuticals labelled as P-gp substrates (e.g. the majority of antidepressants and antipsychotics). A difference in P-gp function was already reported in hepatic P-gp expression. The aim of the current study is to evaluate the influence of gender on cerebral P-gp function. Outcomes of this study can be of great importance in gender-based prescription of P-gp substrate pharmaceuticals.